(Q33692568)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

title

Evolving role of MRI in optimizing the treatment of multiple sclerosis: Canadian Consensus recommendations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

author name string

Douglas L Arnold

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

David Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Marika Hohol

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Santanu Chakraborty

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Jeffrey Chankowsky

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Katayoun Alikhani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Virender Bhan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Walter Montanera

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Hyman Rabinovitch

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

William Morrish

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Robert Vandorpe

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Anthony Traboulsee

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Marcelo Kremenchutzky

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

publication date

1 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

Multiple sclerosis journal - experimental, translational and clinical

22 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

page(s)

2055217315589775

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome

22 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5433339

Predictive value of imaging markers at multiple sclerosis disease onset based on gadolinium- and USPIO-enhanced MRI and machine learning.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5433339

Assessing treatment response to interferon-β: is there a role for MRI?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5433339

Relating relapse and T2 lesion changes to disability progression in multiple sclerosis: a systematic literature review and regression analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5433339

Treatment optimization in MS: Canadian MS Working Group updated recommendations.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5433339

Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5433339

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5433339

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5433339

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5433339

The clinical usefulness of routine MRI assessment.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5433339

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5433339

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5433339

MR imaging in multiple sclerosis: review and recommendations for current practice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5433339

Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5433339

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5433339

Eight-year follow-up study of brain atrophy in patients with MS.

21 June 2018

1 reference

https://api.crossref.org/works/10.1177%2F2055217315589775

Large, nonplateauing relationship between clinical disability and cerebral white matter lesion load in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2055217315589775

Defining interferon beta response status in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2055217315589775

Predictors of long-term outcome in multiple sclerosis patients treated with interferon β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2055217315589775

Scoring treatment response in patients with relapsing multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2055217315589775

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2055217315589775

Disease activity free status: a new end point for a new era in multiple sclerosis clinical research?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2055217315589775

Interpreting therapeutic effect in multiple sclerosis via MRI contrast enhancing lesions: now you see them, now you don't.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2055217315589775

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2055217315589775

MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2055217315589775

Brain atrophy as a non-response predictor to interferon-beta in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2055217315589775

Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2055217315589775

One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2055217315589775

Simple MRI metrics contribute to optimal care of the patient with multiple sclerosis

21 January 2018

1 reference

12 December 2020

Progression in disability and regional grey matter atrophy in relapsing–remitting multiple sclerosis

1 reference

12 December 2020

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

1 reference

12 December 2020

Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study

1 reference

12 December 2020

The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA

1 reference

12 December 2020

Identifiers

DOI

10.1177/2055217315589775

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

PubMed publication ID

28607695

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28607695%20AND%20SRC:MED&resulttype=core&format=json